Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,067,714
-$975,201 QoQ
Shares Held
168,925
-5.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#677
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$36,120
PutShares
1,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verdence Capital Advisors LLC holds $47,881,370 across 14 Drug Manufacturers - General names. PFE ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,223 | $8,663,483 | |
| 2 | JNJ |
Johnson & Johnson
|
31,901 | $8,101,896 | |
| 3 | ABBV |
AbbVie Inc.
|
27,419 | $6,899,717 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,521 | $6,363,448 | |
| 5 | AMGN |
Amgen Inc
|
14,656 | $5,307,230 | |
| 6 | PFE |
Pfizer Inc
This page
|
168,925 | $4,067,714 | |
| 7 | AZN |
Astrazeneca PLC
|
15,469 | $2,933,231 | |
| 8 | SNY |
Sanofi
|
46,110 | $1,967,052 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,120 | 1,500 | Put | Sole | 2026-07-29 | |
| 2026-06-30 | $4,067,714 | 168,925 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,042,915 | 179,591 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,470,894 | 179,554 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,755,842 | 186,650 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,663,827 | 151,148 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $3,162,279 | 124,794 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,014,869 | 113,640 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,709,963 | 128,195 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,602,005 | 128,735 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,670,381 | 132,266 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,436,950 | 119,380 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,481,797 | 135,116 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $5,046,581 | 137,584 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,562,141 | 136,327 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,828,652 | 133,268 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $6,151,780 | 140,580 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,280,534 | 138,862 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $7,414,654 | 143,223 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,091,727 | 120,097 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $5,397,066 | 125,484 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,269,487 | 134,563 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,379,586 | 65,680 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,604,270 | 70,749 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,754,332 | 75,050 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,543,408 | 77,780 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $5,428,873 | 166,326 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||